Irit Van-Ham holds a Ph.D. in Pharmacology from Tel Aviv University and completed postdoctoral work at the University of Ottawa in Canada. She has held senior positions at TEVA Pharmaceuticals and at the Ontario Ministry of Health and is an expert in toxicology and formulation development. Irit leads research and development at ToeFX.
ToeFx Inc. is a research and development company that designs and markets a safe and cost effective solution for the treatment of toenail fungus (onychomycosis). The solution is based on photo-dynamic therapy (PDT) technology, which includes light radiation and a photosensitizer.